Levetiracetam

Application Nr	Approved Date	Route	Status	External Links
ANDA204312	None	Intravenous	None	Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

1 Indications And Usage • Levetiracetam Injection Is Indicated For The Treatment Of Partial-Onset Seizures In Patients 1 Month Of Age And Older ( 1.1 ) • Levetiracetam Injection Is Indicated For Adjunctive Therapy For The Treatment Of: O Myoclonic Seizures In Patients 12 Years Of Age And Older With Juvenile Myoclonic Epilepsy ( 1.2 ) O Primary Generalized Tonic-Clonic Seizures In Patients 6 Years Of Age And Older With Idiopathic Generalized Epilepsy ( 1.3 ) Levetiracetam Injection Is For Intravenous Use Only As An Alternative For Patients When Oral Administration Is Temporarily Not Feasible. ( 1.4 ) 1.1 Partial-Onset Seizures Levetiracetam Injection Is Indicated For The Treatment Of Partial-Onset Seizures In Patients 1 Month Of Age And Older. 1.2 Myoclonic Seizures In Patients With Juvenile Myoclonic Epilepsy Levetiracetam Injection Is Indicated As Adjunctive Therapy For The Treatment Of Myoclonic Seizures In Patients 12 Years Of Age And Older With Juvenile Myoclonic Epilepsy. 1.3 Primary Generalized Tonic-Clonic Seizures Levetiracetam Injection Is Indicated As Adjunctive Therapy For The Treatment Of Primary Generalized Tonic-Clonic Seizures In Adults And Children 6 Years Of Age And Older With Idiopathic Generalized Epilepsy. 1.4 Limitations Of Use Levetiracetam Injection Is For Intravenous Use Only As An Alternative For Patients When Oral Administration Is Temporarily Not Feasible.

None

Name	Structure	ZINC ID(s)
1. Levetiracetam		ZINC1547851